1Wang R, Wu F, Lu H, et al. Definitive intensity-modulated radia- tion therapy for nasopharyngeal carcinoma: long--term outcome of a multicenter prospective study[J]. J Cancer Res Clin Oncol, 2013, 139(1):139-145.
2Wu F, Wang R, Lu H, et al. Concurrent chemoradiotherapy in lo- coregionally advanced nasopharyngeal carcinoma: Treatment out- comes of a prospective, multicentric clinical study[J]. Radiother On- col, 2014, 112(1):106-111.
3A1-Sarraf M, LeBlanc M, Girl PG, et al. Chemoradiotherapy ver- sus radiotherapy in patients with advanced nasopharyngeal cancer: phase HI randonfized Intergroup study 0099[J]. J Clhl Oncol, 1998, 16(4):1310-1317.
4Huang PY, Can KJ, Guo X, et al. A randomized trial of induction chemotherapy plus concurrent chemoradiotherapy versus induction chemotherapy plus radiotherapy for locoregionally advanced naso- pharyngeal carcinoma[I]. Oral Oncology, 2012, 48 (10) : 1038-1044.
5Chen L, Hu CS, Chen XZ, et al. Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal car- cinoma: a phase 3 multicentre randomised controlled trial[J]. TheLancet Oncology, 2012, 13(2):163-171.
6Liang Z, Zhu X, Li L, et al. Concurrent chemoradiotherapy fol- lowed by adjuvant chemotherapy compared with concurrent chemoradiotherapy alone for the treatment of locally advanced na- sopharyngeal carcinoma: a retrospective controlled study[J] Cur- rent oncology, 2014, 21 (3):e408-417.
7Liang ZG, Zhu XD, Tan AH, et al. Induction chemotherapy fol- lowed by concurrent chemoradiotherapy versus concurrent chemo- radiotherapy with or without adjuvant chemotherapy for locore- gionally advanced nasopharyngeal carcinoma: meta-analysis of 1, 096 patients from 11 randomized controlled trials[J]. Asian Pac J Cancer Prey, 2013, 14(1):515-521.
8Sun X, Su S, Chen C, et al. Long'-term outcomes of intensity-mod- dated radiotherapy for 868 patients with nasopharyngeal carcino- ma: an analysis of survival and treatment toxicities[J].adiother Oncol, 2014, 110(3):398-403.
9Zeng L, Tian YM, Sun XM, et al. Late toxicities after intensi- ty-modulated radiotherapy for nasopharyngeal carcinoma: patient and treatment-related risk factors[J]. BrJ Cancer, 2014, 110(1):49-54.
10Peng G, Wang T, Yang KY, et al. A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radio- therapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma[J]. Radiother Oncol, 2012, 104 (3) :286-293.
